Provided by Tiger Fintech (Singapore) Pte. Ltd.

Opyl Ltd

0.022
-0.001-4.35%
Volume:203.35K
Turnover:4.61K
Market Cap:5.17M
PE:-1.70
High:0.023
Open:0.023
Low:0.022
Close:0.023
Loading ...

BRIEF-Opyl Completes A$1.5M Oversubscribed Placement

Reuters
·
02 May

Opyl Ltd - Completion of a$1.5M Oversubscribed Placement

THOMSON REUTERS
·
02 May

BRIEF-Opyl Seeks Trading Halt

Reuters
·
30 Apr

Opyl Ltd - Seeks Trading Halt Pending Announcement on Capital Raising

THOMSON REUTERS
·
30 Apr

ASX Biggest Losers

MT Newswires Live
·
11 Apr

Opyl Signs Service Level Agreement With Avion

MT Newswires Live
·
07 Feb

BRIEF-Opyl Ltd Announces Partnership With Avion

Reuters
·
07 Feb

Opyl Ltd - Opyl and Avion Will Integrate Trialkey Platform Into Clinical Trial Planning

THOMSON REUTERS
·
07 Feb

Opyl Ltd - Announces Partnership With Avion

THOMSON REUTERS
·
07 Feb

BRIEF-Opyl Signs JV With X Firm

Reuters
·
07 Jan

BUZZ-Australia's AI firm Opyl rises on joint venture to expand market penetration

Reuters
·
07 Jan

ASX Small-Cap Stocks to Watch

MT Newswires Live
·
07 Jan

Opyl - Collaboration Aims to Expand Co's Brand Presence and Market Penetration Across Europe, Middle East, Africa, and North America

THOMSON REUTERS
·
07 Jan

Opyl Ltd - Signs Jv With X Firm

THOMSON REUTERS
·
07 Jan

BRIEF-Opyl Partners L39 Capital To Launch Ai-Powered Biotech Fund

Reuters
·
10 Dec 2024

Opyl Ltd - AI Biotech Fund Targets a$100 Million Fum Over Three Years

THOMSON REUTERS
·
10 Dec 2024

Opyl Ltd-Opl Partners L39 Capital to Launch AI-Powered Biotech Fund

THOMSON REUTERS
·
10 Dec 2024

BRIEF-Opyl Signs Service Level Agreement With Southern Clinical Development Consulting

Reuters
·
21 Nov 2024

Opyl Ltd - Signs Service Level Agreement With Southern Clinical Development Consulting

THOMSON REUTERS
·
21 Nov 2024

Opyl Ltd - Agreement Licenses Opyl's Trialkey Platform to Southern Cdc, Enhancing Their Clinical Trial Support, Others

THOMSON REUTERS
·
21 Nov 2024